This Article Full Text Full Text (PDF) All Versions of this Article: 93/5/1641    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Imaizumi, M. Articles by Eguchi, K. Search for Related Content PubMed PubMed Citation Articles by Imaizumi, M. Articles by Eguchi, K. Related Collections Thyroid Endocrine Oncology

Thyroid Diseases in Atomic Bomb Survivors Exposed in Utero

Departments of Clinical Studies (M.I., K.A., K.N., M.A., A.H., N.S., M.S., S.F., M.Y., R.M.) and Statistics (E.N.), Radiation Effects Research Foundation, Nagasaki 850-0013 and Hiroshima 732-0815, Japan; First Department of Internal Medicine (M.I., T.U., K.E), Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan; Sasebo Chuo Hospital (T.T.), Nagasaki 857-1195, Japan; and Japan Radioisotope Association (S.N.), Tokyo 113-8941, Japan

Address all correspondence and requests for reprints to: Misa Imaizumi, M.D., Department of Clinical Studies, Radiation Effects Research Foundation, 1-8-6 Nakagawa, Nagasaki 850-0013, Japan. E-mail: misaima{at}rerf.or.jp.

Objective: The objective of the study was to evaluate the association of thyroid disease with radiation dose in atomic bomb survivors exposed in utero.

Design: This was a cross-sectional study.

Setting: The study was conducted in atomic bomb survivors in Hiroshima and Nagasaki, Japan.

Participants: Participants included 328 atomic bomb survivors exposed in utero (mean age 55.2 yr, 162 males) who participated in the thyroid study at the Radiation Effects Research Foundation. Examinations were conducted between March 2000 and February 2003.

Main Outcome Measures: The relationships of various thyroid conditions to atomic bomb radiation dose were measured.

Results: Among the 319 participants excluding nine participants whose exposure radiation dose was not estimated, the mean maternal uterine radiation dose was 0.256 Gy. We observed no significant dose-response relationship for the prevalence of solid thyroid nodules (odds ratio at 1 Gy, 2.78; 95% confidence interval 0.50–11.80, P = 0.22), but the risk estimate was similar to the estimate for childhood exposures. The prevalence of cysts and autoimmune thyroid diseases was not associated with radiation dose (P > 0.30). We could not evaluate the dose response for malignant tumors or benign nodules due to the small number of cases.

Conclusions: We did not observe a statistically significant linear dose response to radiation for thyroid nodules or autoimmune thyroid diseases 55–58 yr after participants’ in utero exposure. However, the risk estimate for solid thyroid nodules was similar for those exposed in utero and those exposed in childhood. Because the study had limited statistical power to detect moderately sized effects, further studies are needed for a definitive conclusion.